Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (Dry AMD)
This study has been completed.
Astellas Institute for Regenerative Medicine
First Posted: April 29, 2011
Last Update Posted: February 20, 2017
Information provided by (Responsible Party):
Astellas Pharma Inc ( Astellas Institute for Regenerative Medicine )